Assist. Prof. Ant Uzay


Hematologist , Experience: 15

Book Appointment

About Doctor

EDUCATION

2009 Marmara University Faculty of Medicine Hematology

2005 Marmara University Faculty of Medicine Internal Diseases

2000 Trakya University Faculty of Medicine

EXPERIENCE

2009 – 2010 GATA Haydarpaşa Training and Research Hospital / Hematology Specialist Medical Ensign

2005 Acıbadem Healthcare Group

Hospital

Acibadem University Hospital, Istanbul, Turkey

Specialization

Stem cell transplant

 

 

Procedures Performed

 

Research & Publications

  • Prognostic Value of CD49d Expression in Turkish Patients with Chronic Lymphocytic Leukemia2011 – TJH 62687 Ant Uzay, Tayfur Toptas, Isik Kaygusuz, Emel Eksioglu-demiralp, Tulin Firatli Tuglular, Mahmut Bayik
  • Bortezomib in patients with renal impairmentHematology, Volume 16, Number 4, July 2011, pp. 200-208(9) Kaygusuz, Isik; ToptasTayfur; AydinFergun; UzayAnt; Firatli-Tuglular Tulin; Bayik Mahmut
  • Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literatureDepartments of Hematology and Pathology, Medical Faculty, Marmara University, Istanbul, Turkey 2009 APMIS 117: 222-229 Cafer Adıgüzel, Süheyla Uyar Bozkurt, Işık Kaygusuz, Ant Uzay, Tülay Tecimer, Mahmut Bayık
  • Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature Department of Internal Medicine2 Division of Medical Oncology, 3 Division of Hematology, Marmara University School of Medicine, Istanbul, Turkey Journal of BUON14: 511-514, 2009 M.A. Ozturk, F. Dane, I. Kaygusuz, O. Asmaz, A. Uzay, M. Bayik, N.S. Turhal
  • Bortezomib: a new therapeutic option for POEMS syndromeMarmara University School of Medicine, Marmara University, Istanbul, Turkey 2009 European Journal of Haematology 2009, 84 (175-177) Isik Kaygusuz, Hakan Tezcan, Mustafa Cetiner, Ozan Kocakaya, Ant Uzay, Mahmut Bayik Marmara University, Istanbul, Turkey; Department of Internal Medicine

 

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy